Triple-negative breast cancer (TNBC) is characterized by negative expression of estrogen (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) [1]. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.